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Neisseria meningitidis is carried by nearly a billion humans, causing develop-
mental impairment and over 100 000 deaths a year. A quinol-dependent nitric
oxide reductase (qNOR) plays a critical role in the survival of the bacterium in
the human host. X-ray crystallographic analyses of qNOR, including that from
N. meningitidis (NmqNOR) reported here at 3.15 A˚ resolution, show
monomeric assemblies, despite the more active dimeric sample being used for
crystallization. Cryo-electron microscopic analysis of the same chromatographic
fraction of NmqNOR, however, revealed a dimeric assembly at 3.06 A˚
resolution. It is shown that zinc (which is used in crystallization) binding near
the dimer-stabilizing TMII region contributes to the disruption of the dimer. A
similar destabilization is observed in the monomeric (85 kDa) cryo-EM
structure of a mutant (Glu494Ala) qNOR from the opportunistic pathogen
Alcaligenes (Achromobacter) xylosoxidans, which primarily migrates as a
monomer. The monomer–dimer transition of qNORs seen in the cryo-EM and
crystallographic structures has wider implications for structural studies of
multimeric membrane proteins. X-ray crystallographic and cryo-EM structural
analyses have been performed on the same chromatographic fraction of
NmqNOR to high resolution. This represents one of the first examples in which
the two approaches have been used to reveal a monomeric assembly in crystallo
and a dimeric assembly in vitrified cryo-EM grids. A number of factors have
been identified that may trigger the destabilization of helices that are necessary
to preserve the integrity of the dimer. These include zinc binding near the entry
of the putative proton-transfer channel and the preservation of the conforma-
tional integrity of the active site. The mutation near the active site results in
disruption of the active site, causing an additional destabilization of helices
(TMIX and TMX) that flank the proton-transfer channel helices, creating an
inert monomeric enzyme.
1. Introduction
Neisseria meningitidis is carried by about 10% of the popu-
lation of the world in a nonvirulent, asymptomatic form, which
can develop into a pathogenic infection that affects over a
million humans (Pizza & Rappuoli, 2015). A quinol-dependent
nitric oxide reductase (qNOR) plays a critical role in the
survival of the bacterium in the human host by combatting the
host’s immune response. qNORs belong to the broader family
of nitric oxide reductases (NORs). NORs are largely found as
the essential component of anaerobic nitrate respiration,
also known as denitrification, in the bacterial cytoplasmic
membrane and catalyse the reduction of nitric oxide (NO) to
nitrous oxide (N2O). There are three types of respiratory
bacterial NORs: cytochrome c-dependent NORs (cNORs),
dicopper NORs (CuANORs) and qNORs (Hendriks et al.,
2000; Hino et al., 2010; Matsumoto et al., 2012; Shiro et al.,
2012; Al-Attar & De Vries, 2015). Whilst cNORs are pre-
dominantly found in denitrifying organisms as a respiratory
enzyme, qNORs are also found in several pathogenic bacteria,
including the Gram-negative, human-pathogenic bacterium
N. meningitidis, as an enzyme that is responsible for the
detoxification of NO produced by the host (Hendriks et al.,
2000; Anjum et al., 2002; Rock & Moir, 2005). High-resolution
structure determination of N. meningitidis qNOR (NmqNOR)
is of importance to provide a framework for developing a
knowledge-based strategy for the design of new antibacterial
agents, as well as to help to understand the chemistry of NO
reduction, 2NO + 2 H+ + 2e ! N2O + H2O, at the heme and
nonheme iron (FeB) binuclear centre.
NORs have also attracted attention with regard to the
evolutionary aspects of respiratory enzymes. NORs are clas-
sified into the respiratory heme-copper oxidase (HCuO)
superfamily, owing to the active site containing dinuclear
metals in the form of a high-spin heme (heme b3) and either an
iron or a copper ion (Sousa et al., 2012). Pivotal to the HCuO
mechanism is proton pumping across the membrane, coupled
to the reduction of O2 to H2O, generating an electrochemical
gradient which subsequently drives ATP synthase for ATP
generation, which is termed an electrogenic reaction (Tsuki-
hara et al., 1996). Conflicting evidence has appeared for the
electrogenicity of NORs; it has been suggested that cNORs
are non-electrogenic (Hendriks et al., 2000; Hino et al., 2010,
2012), while increasing evidence has appeared for the
electrogenicity of qNORs (Matsumoto et al., 2012; Gonska et
al., 2018), similar to the CuANORs (Al-Attar & De Vries,
2015) there is proton pumping across the membrane during
NO reduction.
All of the crystallographic structures have shown a mono-
meric assembly, despite the fact that all qNORs have been
crystallized from the chromatographic peak that is assigned as
a dimer. Very recently, we determined the structure of
AxqNOR by single-particle cryo-electron microscopy (cryo-
EM) at 3.9 A˚ resolution (Gopalasingam et al., 2019), showing
it to be a dimer; this was the first dimeric structure of an NOR.
In order to elucidate the structural and functional proper-
ties of monomeric and dimeric forms of a qNOR, we focused
on NmqNOR, crystals of which were grown from the dimer
fraction, providing a crystallographic structure at 3.15 A˚
resolution in which it was found to be a monomer. Contrary to
this, cryo-EM analysis of the same fraction gave a dimeric
structure at a resolution of 3.06 A˚. To shed light on the
monomer–dimer structural transition, we produced a number
of point mutations of NmqNOR and Alcaligenes (Achromo-
bacter) xylosoxidans qNOR (AxqNOR). The Glu498Ala
mutant of NmqNOR and the equivalent Glu494Ala mutant of
AxqNOR showed very low NO-reduction activity. We chose
the Glu494Ala mutant of AxqNOR, which primarily migrated
as a monomer on a chromatographic column, to define a cryo-
EM structure of a monomeric qNOR. This provided a 4.5 A˚
resolution structure of a monomeric qNOR for the first time,
showing significant helical rearrangement compared with the
dimeric cryo-EM structures of AxqNOR and NmqNOR,
clearly indicating that the dimer–monomer transition is a key
determinant of active NOR enzymes.
2. Methods
2.1. Purification of recombinant NmqNOR, NmqNOR-BRIL
and AxqNOR Glu494Ala-BRIL
Wild-type and site-directed mutants of NmqNOR were
overexpressed in Escherichia coli C43 or BL21 (DE3) strains
(Lucigen) and were cultured in 2YT and LB media with the
addition of isopropyl -d-1-thiogalactopyranoside (IPTG) to
induce overexpression. The protein was purified using the
detergents n-dodecyl--d-maltoside (DDM; Dojindo) and
n-decyl--d-thiomaltoside (DTM; Anatrace), as previously
reported (Gonska et al., 2018). Apocytochrome b562 (BRIL;
Chu et al., 2002) was fused to the nontruncated C-terminus of
NmqNOR in order to increase the molecular weight to make
cryo-EM analysis tractable. For cryo-EM analysis, NmqNOR-
BRIL was overexpressed and purified in a similar manner as
for the non-BRIL construct, except that glycerol was excluded
during the gel-filtration step. AxqNOR Glu494Ala-BRIL was
expressed and purified in a similar manner to the previously
reported preparation of AxqNOR Val495Ala-BRIL (Gopa-
lasingam et al., 2019).
2.2. UV–visible spectra measurement
UV–visible spectra of NmqNOR were measured using a
Jasco V-630 spectrophotometer. All measurements were made
using a quartz cuvette and the wave scans of samples were
performed in the range 250–700 nm with a 1 nm step. The
preparation of reduced qNOR was performed in an airtight
quartz cuvette with a rubber seal. The sample was reduced by
the addition of 5 mM sodium dithionite (Sigma–Aldrich).
2.3. Measurement of NO consumption by NmqNOR and
NmqNOR-BRIL
NO-reduction activity was determined using an NO elec-
trode (World Precision Instruments) at 20C under anaerobic
conditions. Assay solutions (bubbled with N2 prior to use)
contained 5 ml 50 mM HEPES pH 8.0, 150 mM NaCl and
0.05%(w/v) DDM or DTM (the latter was used forNmqNOR-
BRIL activity measurements). To maintain anaerobic condi-
tions, 10 mM glucose, 50 mg ml1 glucose oxidase and
50 mg ml1 catalase were added to the reaction mixture to
scavenge residual oxygen. 10 mM dithiothreitol and 100 mM
ubiquinone-1 were used as an electron-donation system.
Inhibition-assay activity measurements were performed by
repeating the above experiments with the addition of 150 mM
divalent metal ions (MgCl2, CaCl2, ZnCl2, CdCl2 and ZnSO4)
to the assay mixture (Supplementary Table S2). AxqNOR
Glu494Ala-BRIL activity was measured in a similar fashion as
previously reported (Gopalasingam et al., 2019). NO-
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reduction rates were calculated using the Igor Pro software
package (https://www.wavemetrics.com/).
2.4. Protein crystallization, data collection and structure
determination
NmqNOR crystals were grown from peak 1 chromato-
graphic fractions using the hanging-drop vapour-diffusion
method, with protein at a concentration of 10 mg ml1 and a
reservoir solution consisting of 50 mM HEPES pH 8,
26%(v/v) PEG 600, 0.5 mM ZnSO4. Crystals were cryopro-
tected in 20% glycerol and subsequently flash-cooled and
stored in liquid nitrogen. Diffraction data were obtained to
3.0 A˚ resolution on the BL44XU beamline at SPring-8, Japan
at 100 K using a CCD detector. The data were processed by
iMosflm (Battye et al., 2011) and then scaled using AIMLESS
(Evans & Murshudov, 2013). The structure was solved by
molecular replacement with MOLREP (Vagin & Teplyakov,
2010) using the cryo-EM structure of wild-type AxqNOR as a
starting model (PDB entry 6qq5; Gopalasingam et al., 2019).
The structure was refined by REFMAC5 (Murshudov et al.,
2011) and manually rebuilt within Coot (Emsley et al., 2010).
Data-collection and refinement statistics are included in
Supplementary Table S1.
2.5. Cryo-EM sample vitrification and data acquisition
Prior to cryo-EM screening, negative-stain screening was
performed to confirm the suitability of the sample for cryo-
EM analysis. For cryo-EM data collection, 3 ml NmqNOR-
BRIL (peak 1) at 4 mg ml1 was applied onto glow-discharged
(Pelco) R1.2/R1.3 Cu holey carbon grids (Quantifoil). The
grids were blotted using a blot force of 6 for 6 s and were then
plunge-frozen into liquid ethane using a Vitrobot Mark IV
(Thermo Fisher Scientific) maintained at 4C with 98%
humidity. Screening and data collection took place at the
Astbury BioStructure Laboratory (University of Leeds, UK)
using a Titan Krios (Thermo Fisher Scientific) operating at an
acceleration voltage of 300 kV and equipped with a K2
Summit detector (Gatan) in counting mode. Imaging was
performed at a nominal magnification of 130 000, leading to
a calibrated pixel size of 1.07 A˚ per pixel. A total of 3182
movies were recorded. The dose rate was 8.68 e A˚2 s1
recorded over 8 s, captured in 40 frames, resulting in a total
dose of 69.44 e A˚2, with a defocus range from 1 to
3.5 mm. Data collection was performed using EPU (Thermo
Fisher Scientific). AxqNOR Glu494Ala-BRIL grids were
prepared in a similar fashion to those for NmqNOR-BRIL,
except that a 3 mg ml1 sample from peak 2 was used. Data
were collected at the electron Bio-Imaging Centre, Diamond
Light Source, UK using a Titan Krios (microscope M03)
operating at 300 kV equipped with a K2 Summit detector in
counting mode. Imaging was performed at a nominal magni-
fication of 48 000, leading to a calibrated pixel size of
1.043 A˚ per pixel. A total of 2239 movies were recorded with a
dose rate of 4.66 e A˚2 s1 recorded over 12 s, captured over
40 frames, resulting in a total dose of 55.9 e A˚2, with a
defocus range from 1.5 to 3 mm.
2.6. Image processing of cryo-EM movies
2.6.1. NmqNOR-BRIL (peak 1 fraction). All image
processing was performed in RELION-3.0 (Zivanov et al.,
2018) unless stated otherwise. Movies were motion-corrected
(with dose-weighting) using the RELION-3.0 implementation
of MotionCor. CTF estimation was performed using
CTFFIND 4.1.10 (Rohou & Grigorieff, 2015). An initial 2100
particles were manually picked to generate templates for auto-
picking of all micrographs. After auto-picking, 970 000
particles were extracted (200-pixel box size), which were then
subjected to particle sorting to eliminate ‘junk’ particles. After
sorting, 800 000 particles were subjected to 2D classification
(four rounds with 7 A˚ expectation step limit) which generated
classes with clear dimeric particles and elements of secondary
structure. An initial model was generated (C1 symmetry)
which was then used during 3D classification (K = 4, 10 A˚
expectation step limit) upon filtering to 50 A˚. The best classes
from each round of classification served as references for the
next round. After four rounds of 3D classification with the
previous settings, two rounds (K = 3, no expectation step
resolution limit) of classification left the best class composed
of 233 556 particles. 3D auto-refinement of this class led to a
resolution of 4.2 A˚ in C1 symmetry, with map sharpening
yielding a 3.9 A˚ resolution reconstruction. Refinement in C2
symmetry led to a resolution of 3.7 A˚, with map sharpening
using a tight solvent mask (excluding the detergent belt and
BRIL molecules, with 6 pixels cosine edge added) improving
the resolution to 3.4 A˚. These particles were then subjected to
CTF refinement, with CTF parameter fitting and re-estimation
of per-particle defocus values. Refinement and map shar-
pening led to a map of 3.5 A˚ resolution, before Bayesian
particle polishing was performed using all movie frames and
parameters previously determined from a training step which
used 25 000 particles. The ‘shiny’ particles were auto-refined
to 3.3 A˚ resolution, with map sharpening using a tight mask
leading to a final resolution of 3.06 A˚. All resolution estimates
were calculated using the ‘gold standard’ Fourier shell corre-
lation (FSC) = 0.143 (Scheres & Chen, 2012). ResMap version
1.95 (Kucukelbir et al., 2014) was used to assess slices through
local resolution estimates, using the default finest and coarsest
resolution limits (2 and 4 pixel size, respectively). Map
volumes and masks were visualized in UCSF Chimera version
1.13.1 (Pettersen et al., 2004).
2.6.2. AxqNOR Glu494Ala-BRIL (peak 2 fraction). The
AxqNOR Glu494Ala-BRIL peak 2 (85 kDa) data were
processed in a similar fashion to those for NmqNOR-BRIL,
except for the 3D classification steps. After several rounds of
2D classification (box size 150 pixels), an initial model was
generated (C1 symmetry) that clearly showed a monomeric
structure. 3D classification was performed using a regulariza-
tion parameter (T) of 8 as opposed to the default of 4, to
increase the weighting towards the experimental data, as
performed during image processing of sub-100 kDa protein
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complexes (Herzik et al., 2019). Three rounds of classification
(K = 3, expectation step limit of 8 A˚) yielded two classes
comprising 150 000 particles (from an initial particle set of
680 000). Auto refinement led to a global resolution of 5 A˚.
CTF refinement (per-particle defocus value re-estimation) and
Bayesian particle polishing followed before a final round of
2D classification, leaving 144 000 polished particles. Auto
refinement led to a resolution of 5.05 A˚ and refinement was
continued with a soft mask (encompassing the BRIL and
detergent micelle), improving the resolution to 4.88 A˚. Map
sharpening with a tight mask, which excluded BRIL (with a
soft cosine edge of 6 pixels), led to a final map at 4.5 A˚
resolution (using ‘gold standard’ FSC = 0.143), with the local
resolution of the core valued at 4.2 A˚ (as judged by
RELION-3.0).
2.7. Model building and refinement of cryo-EM structures
2.7.1. NmqNOR-BRIL. The X-ray model of NmqNOR
(from this work) was rigidly docked into the final cryo-EM
map using the UCSF Chimera ‘Fit in Map’ function before
visualization in Coot. In parallel, the ARP/wARP (Langer et
al., 2008) EM webserver (https://arpwarp.embl-hamburg.de/)
was also used to build the model ab initio. ARP/wARP
correctly identified and positioned 96% of the residues. When
manual model building took place, the missing loop regions on
the cytoplasmic side and modified helices were taken from the
ARP/wARP EM webserver model. Once built, the model was
real-space refined using the phenix.real_space_refine module
in Phenix version 1.15 (Afonine et al., 2018), imposing
secondary-structure and noncrystallographic symmetry (NCS)
restraints. Model morphing was only performed once at the
start of each refinement. After several rounds of manual
building in Coot and refinement, validation of the model was
performed using MolProbity (Williams et al., 2018). Cross-
validation of the refined model was performed to test for
overfitting (Brown et al., 2015). The refined model was
‘shaken’ by inducing random 0.5 A˚ shifts in the atomic co-
ordinates, which was performed in phenix.pdbtools within
Phenix. The shaken model was then refined against the first
half map. The shaken-refined model was used to calculate the
FSC against the same half map as used in refinement
(FSCwork), against the second half map that was not used in
refinement (FSCfree) and finally against the summed map
(FSCsum). These were performed in phenix.mtriage within
Phenix. The minor difference between the FSCwork and
FSCfree curves indicated no major overfitting of the model into
the maps.
2.7.2. AxqNOR Glu494Ala-BRIL. The AxqNOR Glu494Ala
structure was refined with phenix.real_space_refine in Phenix
version 1.15 without the nonheme Fe. The Glu490 and His486
side chains were also removed from the model as no clear
density was observed. Secondary-structure, Ramachandran
and rotamer restraints were applied during refinement, with
model morphing performed once at the start of refinement.
Owing to the lower resolution of the density map, tighter
geometry restraints were employed in the early rounds of
refinement by lowering the weighting term from the default of
50 to 25, which greatly reduced the all-atom clashscore and
improved the overall geometry. Further improvements were
made by employing reference-based restraints using the
AxqNOR Val495Ala structure (PDB entry 6qq6; Gopala-
singam et al., 2019) as a reference model. Coot was used to
manually rebuild the model, with validation performed using
MolProbity. As with all qNOR-BRIL cryo-EM structures thus
far, the BRIL portion was not built into the model owing to a
lack of clear, detailed density as a result of its flexibility. Cross-
validation of the refined model was performed in the same
manner as for NmqNOR-BRIL.
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Figure 1
Biochemical characterization of NmqNOR. (a) Size-exclusion chromato-
graphy of NmqNOR. The solid curve shows the BRIL construct of
NmqNOR and the broken curve shows the wild-type NmqNOR trace at
280 nm absorbance. Two types of fractions were observed in both
constructs, which are indicated by the labels P1 for dimer and P2 for
monomer (the red dashed line shows the divide between peak 1 and peak
2). (b) Blue native gel experiment for both fractions (P1 and P2) after
concentration in 100 kDa cutoff centrifugal filtration devices (Amicon).
Both 5 mg (labelled 5) and 10 mg (labelled 10) of each fraction was loaded
onto the gel. Peak 1 samples migrate as the higher molecular-weight
species (242 kDa), whilst peak 2 samples migrate between 66 and
146 kDa. Two bands of the high and low molecular-weight species could
be observed in both peak fractions when loaded with 10 mg sample, which
indicate a slight mixture of monomer and dimer in both peak 1 and peak
2. LaneM, native PAGE marker, with values corresponding to molecular
weight in kDa. (c) NO-reduction activity measurement of both peak 1
and peak 2 fractions. Peak 1 (solid curve) shows a higher NO-reduction
activity compared with peak 2 (broken curve).
3. Results
3.1. Oligomerization state of NmqNOR
During size-exclusion chromatography, NmqNOR displays
a dimer–monomer mixture upon elution, with the majority of
the protein in the peak 1 fraction [Fig. 1(a)]. This behaviour is
not owing to the detergent exchange from DDM to DTM, as
the migration is essentially identical. To assess the oligomeric
state, we subjected the peak 1 and peak 2 fractions to non-
denaturing gel electrophoresis (blue native PAGE). Pre-
dominantly, peak 1 migrated to 242 kDa [consistent with
dimeric NmqNOR (90 kDa  2) plus the detergent micelle
(60 kDa)], whilst peak 2 migrated between 66 and 146 kDa.
The gel indicated that both peaks had a slight mixed species
behaviour when the sample concentration was increased
[Fig. 1(b)]. NO reduction of each peak was conducted, with
peak 1 exhibiting a higher steady-state NO-reduction activity
compared with the peak 2 sample [Fig. 1(c)]. This is similar to
AxqNOR, but contrasts with bovine cytochrome c oxidase
(CcO), where the activity of the monomeric species was found
to be twice that of the dimeric form. The latter of these had
previously been observed in crystal structures, until recently,
when a monomeric bovine CcO structure was reported
(Shinzawa-Itoh et al., 2019). Metal-content measurement was
performed after purification for both peak fractions of
NmqNOR, showing that three Fe atoms and no zinc were
present in the sample solution. Nonheme iron is present in
both peaks at full occupancy. UV–visible spectra (oxidized
and reduced) shows similar band positions from both peak
fractions, indicating electronic equivalence of the active site
for both peaks [Supplementary Figs. S1(a) and S1(b)].
3.2. Crystal structure of NmqNOR
The best, highly diffracting crystals of NmqNOR only grew
in the presence of zinc sulfate, which was used in the crystal-
lization condition. The crystals diffracted to 3 A˚ resolution,
leading to a refined structure at 3.15 A˚ resolution in space
group P212121 (Supplementary Table S1), revealing only a
monomer in the crystal lattice. The crystallization condition
was similar for a bacterial CcO, where higher resolution
crystals were only obtained in the presence of divalent metal
cations (Qin et al., 2007). The overall monomeric structure of
NmqNOR contains 14 transmembrane helices (TMs) and the
positions of heme b, heme b3 and FeB are well defined
[Fig. 2(a)] (Gonska et al., 2018). FeB was ligated by three
conserved histidines (His490, His541 and His542). Addition-
ally, three Zn2+-binding sites were observed, of which the Zn1
and Zn2 binding locations were particularly important in
order to understand the properties of the proton-transfer
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Figure 2
Monomeric, zinc-bound crystallographic structure of NmqNOR. (a) Monomeric NmqNOR crystal structure with three zinc-binding sites (grey spheres;
Zn1, Zn2 and Zn3) and with the periplasmic (Peri0) and cytoplasmic (Cyt0) ends of the lipid bilayer marked with yellow lines. (b) The Zn1 binding site
near the proposed proton-entry site at the cytoplasmic end; the 2Fo  Fc density map is shown as a blue mesh, with Zn1 ligated by His257 (contoured at
1.9), Glu573 (contoured at 2.4), Glu576 (contoured at 3) and His577 (contoured at 2) (salmon sticks), (c) Zn2 is located close to the binuclear
centre (heme b3 and FeB; brown sphere), where it is bound by three conserved glutamates [Glu498 (1.5), Glu494 (1) and Glu563 (1)]. FeB is ligated
by only three histidines (His490, His541 and His542; all contoured at 1.5), with extra density between the heme b3 iron and nonheme iron modelled as a
water (red sphere).
pathway. Zn1 is positioned near TMII, close to the predicted
entry to the water channel, and is ligated by His257, Glu573,
Glu576 and His577 [Fig. 2(b)]. The Zn2 ion was bound by
three carboxylate groups from Glu494, Glu498 and Glu563,
which are located towards the end of the putative proton-
transfer water channel, in which Glu494 is too far away for
coordination of FeB [Fig. 2(c)]. The third binding site for Zn
(Zn3) was observed near the periplasmic region where the
zinc ion has three waters bound, in addition to His172, which
itself is ligated to Glu709.
3.3. Inhibition of NO reduction by metal ions
In view of the zinc binding in the crystallographic structure
of NmqNOR, we tested the effect of several divalent metals,
including zinc, on NO reduction of both NmqNOR and
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Figure 3
Cryo-EM analysis of the active NmqNOR dimer. (a) 2D class averages of dimeric NmqNOR particles in multiple orientations after particle polishing,
prior to the final 3D refinement (box size of 200 pixels). (b) 3D reconstruction from cryo-EM filtered and coloured by local resolution (as estimated in
RELION-3.0), with the core of the structure being valued at 3 A˚ (as indicated by the colour key at the bottom). (c) NmqNOR dimeric model after
structure refinement and model building docked into the sharpened cryo-EM-derived map (grey outline). Chains are coloured as purple and cyan
cartoons, respectively. Yellow lines mark the lipid bilayer and subsequently the periplasmic (Peri0) and cytoplasmic (Cyt0) sides. The red dashed line
indicates the location of TMII. (d) The dimer interface of NmqNOR is mediated by TMII (purple and cyan helices) of each monomer. Val237, Leu240,
Leu241 and Ile244 (map contoured at 7) are likely to stabilize the dimeric form of NmqNOR.
AxqNOR (Supplementary Table S2). The presence of zinc
totally abolished the NO-reductase activity for both enzymes,
while the presence of other divalent cations, such as magne-
sium and calcium, did not significantly reduce the activity.
These results are largely comparable to that of CcO, in that
both zinc and cadmium are potent inhibitors of activity (Qin et
al., 2007), suggesting that qNORs also suffer from proton-
transfer inhibition owing to zinc/cadmium binding.
3.4. Cryo-EM of NmqNOR reveals a dimeric structure
Given the monomeric crystallographic structure of
NmqNOR, apocytochrome b562 (BRIL; Chu et al., 2002) was
fused to the nontruncated C-terminus ofNmqNOR in order to
increase the molecular weight to make cryo-EM analysis
tractable [Supplementary Fig. S2(a)]. Previous attempts to
obtain a reconstruction in the absence of BRIL resulted in an
9 A˚ resolution map with a lack of clear secondary-structure
features, as reported in Gopalasingam et al. (2019). The NO-
reduction activity of NmqNOR-BRIL showed no significant
difference compared with that of wild-type NmqNOR. After
negative-staining imaging to confirm the homogeneity and
integrity of the sample, grids were prepared for cryo-EM
analysis. From 3182 micrographs, 972 078 initial particles were
extracted, before being reduced to 233 556 particles through
iterative cycles of 2D and 3D classification [Fig. 3(a)]. For the
final 3D reconstruction with C2 symmetry imposed, a final
global resolution of 3.06 A˚ was achieved, as judged by the
‘gold standard’ FSC = 0.143 (Supplementary Table S2 and
Supplementary Fig. S3). The density for the BRIL portion was
at a lower resolution compared with the NmqNOR molecule,
presumably owing to the flexibility of BRIL, and was subse-
quently not built into the model [Fig. 3(b), Supplementary Fig.
S2(c)]. Unlike in the crystal structure [Fig. 2(a)], the peak 1
fraction used for cryo-EM revealed NmqNOR to be in a
dimeric arrangement, akin to the cryo-EM structure of
AxqNOR [Fig. 3(c)]. This dimeric structure is maintained by
TMII of both monomers, with four amino-acid residues
maintaining the interface: Val237, Leu240, Leu241 and Ile244
[Fig. 3(d)]. These four residues are highly conserved amongst
most qNORs (Supplementary Fig. S4), in which they are likely
to play significant roles in qNOR dimerization.
The cryo-EM density map was more detailed than the
crystallographic electron-density maps, in which heme b, heme
b3, FeB and their associated ligands could be modelled with
confidence. The coordination of the active site in the absence
of zinc was observed by cryo-EM, which interestingly showed
that FeB was ligated by four ligands: the three conserved
histidine ligands (His490, His541 and His542) and Glu494
[Fig. 4(a)]. The ligation mode of Glu494 is different from that
in the previously reported (inactive) crystal structure of
Geobacillus stearothermophilus qNOR (GsqNOR) and in the
activeAxqNOR structure obtained by cryo-EM, both of which
showed trihistidyl ligand coordination of FeB (Matsumoto et
al., 2012; Gopalasingam et al., 2019) [Fig. 4(b)]. The orienta-
tion of this conserved glutamate in the NmqNOR cryo-EM
structure is similar to that of Pseudomonas aeruginosa cNOR
(PacNOR; Hino et al., 2010), except that in PacNOR FeB was
coordinated by both carboxyl O atoms of the glutamate (at
distances of 2 and 2.5 A˚), while in the NmqNOR cryo-EM
structure FeB is coordinated by a single carboxyl O atom (O
"1)
from Glu494, separated by 2.4 A˚ [Fig. 4(c)]. Another differ-
ence in the active sites of the NmqNOR EM structure and the
cryo-EM structure of AxqNOR is the distance between FeB
and the heme b3 iron, which is 4.5 A˚ in this structure and 4.1 A˚
in AxqNOR. These differences in the active-site structure may
reflect a significant difference in NO-reduction activity for the
two qNOR enzymes (Supplementary Table S2).
This higher quality of the resultant structure enabled us to
investigate the details of the putative proton-transfer water
channel in this electrogenic enzyme. A large cavity was
observed from the cytoplasmic region near residues Ser252,
Thr255, Glu259, Tyr575, Glu576 and Ser579 towards the active
site [Supplementary Fig. S5(a)]. This helps to rationalize our
previous site-directed mutagenesis study of the proposed
water-entry channel, in which Glu259 variants had no detri-
mental effect on NmqNOR activity, as the channel may be too
large, allowing some potential redundancy in proton path-
way(s) (Gonska et al., 2018).
The dimeric structure of NmqNOR is largely maintained by
TMII, similar to as in AxqNOR. Along TMII, structural
analysis using PyMOL (version 1.8; Schro¨dinger) revealed a
cavity that bridges the dimeric interface connecting the two
monomers [Supplementary Figs. S5(b) and S5(c)]. There are
several residues which maintain this cavity: Tyr251, Ser252,
Thr255 and Arg572. These in turn connect with the charged
residues that line the putative proton-transfer water pathways
of the respective monomers. This pathway consists of several
charged and ionizable residues, starting from Glu259, Ser579
and His582, and followed by Glu573, His577, Glu576, Ser523,
Thr502 and Ala527 [Fig. 4(d)]. At the end of this putative
water channel lie Glu498 and Asn604, which are ligated and
may serve as a ‘junction’ that is responsible for controlling the
proton before entering the active site; our previous study
shows that mutation of Glu498 reduces the activity of this
enzyme (Gonska et al., 2018). The same effect was found in
AxqNOR, with Asn600 (equivalent to Asn604 in NmqNOR)
being critical for activity [as also confirmed in Persephonella
marina qNOR (PmqNOR; Sheraden, 2013)], with residues
closer to the active site of NmqNOR and AxqNOR being
more conserved in residue type and orientation compared
with those lower down (i.e. towards the cytoplasmic end of)
the putative proton-transfer water channel (Supplementary
Fig. S6 and Supplementary Table S4).
3.5. The cryo-EM structure of monomeric AxqNOR
Glu494Ala provides insight into the dimer–monomer
transition of qNORs
Glu498 variants in NmqNOR resulted in a loss of activity of
greater than 90%, with the same effect holding true for the
corresponding residue in AxqNOR (Glu494). This residue is
fully conserved amongst all NORs and is believed to partake
in proton transfer towards the active site in qNORs, being
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hydrogen-bonded to Asn600 in AxqNOR (Asn604 in
NmqNOR) [Fig. 5(a)], in the aforementioned ‘junction’ before
the active site. The AxqNOR Glu494Ala-BRIL variant puri-
fied largely as a monomeric species [Supplementary Fig.
S7(a)], in contrast to the purification profiles of the wild type
and other mutant enzymes. The Glu494Ala monomeric
species was inactive, while the dimeric species showed a
detectable NO-reduction activity of less than 10%
[Supplementary Fig. S7(b)]. The predominance of the
monomeric peak for this mutant provided an opportunity to
determine the cryo-EM structure of the monomeric species
in order to help to ascertain the structural elements that
may play a role in the dimer–monomer transition of
qNORs.
research papers
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Figure 4
Active-site configuration and proton-transfer channel in the dimeric cryo-EM structure of NmqNOR. (a) Active site of the ‘native’ NmqNOR cryo-EM
structure with the corresponding density, showing FeB (brown sphere) to be ligated by four ligands (Glu494, His490, His541 and His542), with Glu494
contoured at 4 and the histidines at 8. The Glu494–FeB bond is shown as a red dashed line (2.4 A˚) and the trihistidyl–FeB coordination is shown as
black dashed lines. (b) Comparison between the active-site structures of PacNOR (transparent pink sticks), AxqNOR V495A (transparent magenta
sticks) and NmqNOR (cyan sticks), clearly showing that the terminal glutamate of PacNOR and NmqNOR (Glu494) ligates FeB (black and red dashed
lines, respectively). Glu494 may display flexibility as part of its function in proton transfer, as the equivalent glutamate in AxqNOR ligates a water
(orange sphere) in lieu of FeB. (c) Top: active site of PacNOR (PDB entry 3o0r; Hino et al., 2010), with Glu211 (equivalent to Glu494 in NmqNOR)
ligating FeB (purple sphere) in a bidentate fashion, as shown by the black dashed lines (distances are also shown). Bottom: active site ofAxqNORV495A
(PDB entry 6qq6) showing Glu490 (equivalent to Glu494 in NmqNOR) ligating a water molecule (Wat; orange sphere), with FeB (yellow sphere) having
trihistidyl coordination. (d) Putative proton-transfer channel in NmqNOR, with residues shown as cyan sticks and contoured at 6 (except for Glu259
and Glu573, which are both contoured at 4). Asn604 and Glu498 are hydrogen-bonded (black dashed line) in the cryo-EM structure; FeB and calcium
ions are shown as brown and green spheres, respectively.
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The structure of the 85 kDa monomer was determined to
4.5 A˚ resolution [Supplementary Table S3, Supplementary
Figs. S7(c)–S7(e)] by cryo-EM. The BRIL portion could not be
built owing to its greater flexibility and limited resolution
[Supplementary Figs. S2(b) and S2(d)]. The structure revealed
large movements of TMI (10 A˚ displacement of the Val17 C
atom) and the dimer-stabilizing TMII helix [Fig. 5(b)] relative
to the wild-type enzyme structure [Fig. 5(c)]. TMX was also
shifted across and into the putative proton-transfer channel
(8 A˚ movement of the Ile564 C atom), acting to potentially
perturb the channel [Fig. 5(d)]. TMX contains Glu569, which
was found to interact with Ser523 (on TMIX) in the wild-type
structure, with the substitution of the latter causing a 70% loss
of activity, believed to be owing to the loss of the Glu569
interaction.
This is likely to be disrupted as a consequence of the
Glu494Ala point mutation. Additionally, the binuclear centre
was perturbed, with no density for His486 and a weak density
at the position expected for the nonheme iron (this iron was
therefore removed from the model) [Fig. 5(e)]. TMIX, which
contains two of the three FeB ligands, His537 and His538, is
very distorted. The loss of iron may itself result in these
conformational changes or they may induce a weakening of
the iron-binding site. Regardless, they cause more pronounced
changes of the dimer-stabilization and proton channel-
flanking helices, confirming Glu494 to be a critical residue not
only for activity but also for structural maintenance of the
dimer and active site in AxqNOR.
4. Discussion
4.1. Structural comparison of the crystallographic monomer
and the cryo-EM dimer of NmqNOR
Based on our results, the crystal and cryo-EM structures of
NmqNOR have different active-site arrangements. For the
crystal structure, the crystal was grown under zinc-containing
conditions, which led to the observation of three zinc-binding
sites, with the Zn2 binding site affecting the conformation of
Glu494. However, a native dimeric structure was observed in
the cryo-EM structure as the data were collected without any
additional buffer components; in this structure Glu494 was
ligated to FeB, which we believe is the natural position for
Glu494 [Fig. 6(a)]. However, knowing that the inhibitor (zinc)
binds toward the end of putative water channel [Fig. 2(c)] in
the crystal structure, Glu494 may possess some flexibility
Figure 5
Proton-transfer inhibition in a monomer of AxqNOR Glu494Ala. (a) The location of Glu494 (magenta sticks) in wild-type AxqNOR (teal cartoon; PDB
entry 6qq5) relative to the dimer-stabilizing TMII. (b) 4.5 A˚ resolutionAxqNORGlu494Ala peak 2 cryo-EM-derived density map (khaki) with wild-type
AxqNOR (teal cartoon) rigidly docked into the map, showing displacement of TMI and TMII. (c) Alignment of wild-type AxqNOR (teal cylinders) and
the AxqNOR Glu494Ala peak 2 structure (orange cylinders), with an overall r.m.s.d. of 1.06 A˚, with the helices showing the greatest displacement, TMI,
TMII, TMIX and TMX, labelled with roman numerals. (d) Disruption of the putative proton-transfer channel by movement of TMX of the AxqNOR
Glu494Ala peak 2 structure (orange) across the cavity (8 A˚ from Ile564C), with the Glu569–Ser523 interaction in the wild-type structure (teal) likely
to be perturbed as a result. Asn600 shows a conserved conformation, despite being hydrogen-bonded to Glu494 in the wild-type structure. (e) Binuclear
centre of the AxqNOR Glu494Ala monomer (orange cartoon, grey cryo-EM density map contoured at 3) compared with wild-type AxqNOR (teal
cartoon), with no density for His486 (omitted from the AxqNOR Glu494Ala peak 2 model) and unclear density for the nonheme metal. The His537 and
His538 conformations are significantly altered in the absence of the nonheme metal and could contribute to downstream structural movements.
between FeB and the end of the putative proton-transfer
pathway, as seen in AxqNOR (Gopalasingam et al., 2019).
From the overall structure, TMII in the crystal structure
moves significantly outwards compared with the cryo-EM
structure. The TMII helix is clearly important for maintaining
the dimer interface, and a distortion of this helix may be a
driver for disruption of the active dimer [Fig. 6(b)].
Another possible reason was the location of Zn1 binding in
the early part of the putative proton-transfer pathway. Three
amino acids which bind Zn1 may be responsible for the
putative proton-transfer pathway and cavity formation/main-
tenance, as observed in the dimeric cryo-EM structure and
shown in Supplementary Fig. S5(c). This binding of Zn1 might
be responsible for the change in cavity structure and also the
loss of activity in the presence of zinc, and affect the position
of TMII in the crystal structure. The position of His577 in the
cryo-EM structure was moved upwards and Glu576 and
Glu573 were moved downwards in order to accommodate
space for the potential water pathway in the cavity; however,
in the crystal structure all three of these residues bind atom
Zn1 [Fig. 6(c)]. Alignment of the monomer and dimer struc-
tures of NmqNOR shows that Zn1 binding may cause the
TMII loop region to splay away and into the symmetry-related
molecule of the dimer, specifically clashing with TMX
(Supplementary Fig. S8). This structural change may be an
important factor in the dissolution of the dimer in crystallo.
4.2. Active-site structure of NmqNOR
Based on the structure of active AxqNOR and the inactive
crystal structure ofGsqNOR, it has been suggested that FeB of
qNOR is ligated by only three conserved histidine ligands. The
cryo-EM structure of NmqNOR, like AxqNOR, is dimeric;
however, FeB has four ligands. The activity of NmqNOR is an
order of magnitude higher than that of AxqNOR, which may
arise from this difference in the ligand environment of the
active site. We suggest that Glu494 (NmqNOR numbering)
plays a vital role as a final proton acceptor before transferring
the proton to the active site for NO reduction. The flexible
nature of this catalytically essential Glu494 might be unique to
qNOR and a key property for fulfilling its function of proton
transfer from either Glu498 or Glu563. The result of zinc
binding in the Zn2 site shows that these three main glutamates
(Glu498, Glu494 and Glu563) were grouped together by zinc
binding, in which Glu494 can receive protons either directly
from Glu498 or through Glu563. Whether the flexibility of
glutamate facilitates the accommodation of two NOmolecules
for NO reduction in the active site remains an open question.
4.3. Putative proton-transfer water channel
Zn2+ and Cd2+ ions have been utilized in several membrane-
protein complexes in order to understand their respective
proton-transfer pathways. These include bacterial and bovine
CcO, the cytochrome bc1 complex and the photosynthetic light
reaction centre (Schubert et al., 1997; Berry et al., 2000;
Muramoto et al., 2007; Qin et al., 2007). Zinc binds towards the
D-pathway in bovine CcO and the K-pathway in bacterial
CcO; thus, as a part of the HCuO family, the properties of Zn
and Cd in binding either towards the imidazole ring of histi-
dine and three carboxyl groups has proven to be very useful in
order to understand the properties of the proton pathway in
NmqNOR. The Zn1 and Zn2 binding sites were crucial in this
study, as we predict that the Zn1 binding site is at the entrance
to the putative proton-transfer water channel and that the Zn2
binding site represents the end of the channel. Previously, we
showed that site-directed mutagenesis around the entrance
research papers
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Figure 6
Comparison of dimeric cryo-EM and monomeric crystallographic
NmqNOR structures. (a) In the crystallographic structure (salmon
sticks), the Zn2 binding site (grey sphere) interferes with FeB (magenta
sphere), as Glu494 is helping to coordinate Zn2 (yellow dashed lines),
whilst the native, non-zinc-bound cryo-EM-derived structure (cyan
sticks) shows Glu494 to ligate FeB (brown sphere) in a monodentate
fashion via the O"1 atom, as shown by the red dashed line. (b) Alignment
of the crystallographic (salmon cartoon) and cryo-EM structures (one
protomer of the dimer is shown as a cyan cartoon) shows distortion of
TMII in the crystal structure, possibly owing to the absence of a
neighbouring molecule. TMX is also heavily perturbed, possibly owing to
Zn1 binding [black dashed box, elaborated in (c)]. (c) Zn1 binding causes
significant helical movement of TMX, with the cryo-EM TMX shifted
inwards, with Glu573, Glu576 and His577 facing towards the putative
proton-transfer channel/solvent in the absence of zinc, with His257 facing
towards the cytoplasmic end.
does not have any significant effect on the activity of
NmqNOR (Gonska et al., 2018), which is consistent with the
large cavity entrance towards the catalytic site. To our
knowledge, qNOR is the only member of the HCuOs that has
a large water cavity from the cytoplasmic end towards the
active site.
The opening cavity of the water channel is formed by
several residues (Ser252, Thr255, His257, Glu259 and Ser579).
The cavity then moves upwards and broadens between Glu573
and Ser523. At the end of the putative proton-transfer
pathway observed in the cryo-EM-derived structure, it is
shown that the proton-transfer pathway could be controlled
by two amino-acid residues: Glu498 and Asn604. This is
further validated by the binding of zinc (in the Zn2 location)
and the previously reported site-directed mutagenesis of
Glu498, which has significant effects on abolishing activity. We
expect that the putative water channel terminates here, and
protons are transferred towards Glu563, mediated by the
flexible Glu494. Alternatively, transfer of protons can occur
directly from Glu498 to Glu494, ultimately reaching the active
site. The monomeric, inactive structure of AxqNOR
Glu494Ala revealed unexpected structural rearrangements at
the active site and several helices. TMII undergoes a slight
displacement, while the helices TMIX and TMX, which help
to maintain the putative proton-transfer channel, revealed a
more drastic change [Supplementary Fig. S8(b)]. The distur-
bance at the active site probably had a knock-on effect on the
overall structure of TMX (which contains His537 and His538,
two of the FeB ligands). Interestingly, TMVIII (which contains
Glu494 and His486, the third FeB ligand) shows little re-
arrangement, along with TMXII, which contains Asn600
(previously shown to interact with Glu494). Similarly, in
NmqNOR movement of TMXI across and into the putative
channel may weaken the interaction with the symmetry-
related TMII [Supplementary Fig. S8(a)], possibly contri-
buting to the dimer–monomer transition. These movements
and the consequent destabilization of the TMIX and TMX
helices in AxqNOR Glu494Ala clearly weaken the dimeric
arrangement and result in the mutant purifying primarily as a
monomer.
Activity measurements of the wild-type qNORs show that
the dimeric peak obtained from SEC had higher activity than
the monomeric peak. Structurally, this may be owing to TMII,
which resides close to the entrance of the proton-transfer
pathway in the symmetry-related monomers, as was clearly
observed in the cryo-EM structure. The dimeric structure may
cause increased stability of qNORs in the maintenance of the
proton-transfer pathway, and this was clearly seen in the
distortion of TMII in the monomeric crystal structure, where
the helix moves outwards and away from the rest of the
molecule when compared with the cryo-EM structure
[Supplementary Fig. S7(a)]. However, it is not clear whether
this distortion occurs owing to any effect resulting from zinc
binding in the Zn2 site in the proton pathway, as seen in the
crystal structure. The stability of the dimeric structure may
synergize the proton pathway of two monomers owing to the
cavity connection mentioned previously. This raises the
possibility that the proton entry is shared between two
monomers and increases the proton passage by way of
widening the channels in the dimeric structure. For the related
CcO (bovine), however, the monomeric form has been found
to be more active at a variety of pH values. In that case, the
structure revealed the K-pathway hydrogen-bonded network
of water molecules to be continuous and unrestricted, whereas
in the dimeric structures (Supplementary Fig. S9) cholate
interrupts this network near the dimer interface (Shinzawa-
Itoh et al., 2019).
5. Concluding remarks
In summary, we have solved the high-resolution structure of
wild-type NmqNOR by cryo-EM at 3.06 A˚ resolution and that
of inhibitor (zinc)-bound NmqNOR by X-ray crystallography
at 3.15 A˚ resolution. The overall dimeric cryo-EM structure of
NmqNOR is similar to the dimeric cryo-EM structure of
AxqNOR, which together represent the structure of active
qNOR in the native state. The presence of a dimeric qNOR
may serve an environmental advantage for N. meningitidis
(andA. xylosoxidans, an opportunistic pathogen; Awadh et al.,
2017) to proliferate under host cell-produced NO as a means
of both detoxifying toxic byproducts and conserving energy.
The monomeric crystallographic structure of NmqNOR may
result from disruption of the dimer interface owing to zinc
binding near the dimer-stabilizing TMII region. The role of the
TMII region in stabilizing the dimer is reinforced by the
monomeric cryo-EM structure of the Glu494Ala mutant of
AxqNOR. The single mutation results in active-site distur-
bance of nonheme iron ligands, culminating in displacement of
the dimer-stabilizing TMII and the putative proton-transfer
channel flanking helices TMIX and TMX, acting to create a
catalytically inert monomeric qNOR. The monomer–dimer
transition of qNORs seen in cryo-EM and crystallographic
structures has wider implications for structural studies of
multimeric membrane proteins.
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